OAK 0011379
Alternative Names: OAK-0011379Latest Information Update: 24 Nov 2023
At a glance
- Originator Blue Oak Pharmaceuticals
- Class Antidepressants
- Mechanism of Action Neuron modulators; Neurotransmitter modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bipolar depression
Most Recent Events
- 08 Nov 2023 Preclinical trials in Bipolar depression in USA (unspecified route)